Claritin Drives Schering-Plough Consumer Health First-Quarter Sales
This article was originally published in The Tan Sheet
Executive Summary
A 15 percent increase in over-the-counter sales of Claritin was a primary growth driver for Schering-Plough's Consumer Health Care division during the first part of 2007
You may also be interested in...
Schering Prepares For “Turnaround”; Claritin Falls Flat In First Quarter
Schering-Plough's Claritin experienced another relatively flat quarter despite an increase in promotional spending
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement